Stocks · Korea
153710
KOSDAQ
Optipharm
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W-2.18%
1M-6.96%
3M-0.44%
6M-11.29%
1Y-14.18%
YTD-12.84%
52W high6,250원
52W low4,075원
From 52W high-28.32%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 160억 | -34억 | -20억 | -21.1% |
| 2023 | 174억 | -26억 | -24억 | -15.1% |
| 2024 | 196억 | -25억 | -24억 | -12.5% |
| 2025 | 223억 | -24억 | -25억 | -10.8% |
| Quarterly | ||||
| 2024 4Q | 56억 | -3억 | -2억 | -4.5% |
| 2025 1Q | 49억 | -11억 | -11억 | -23.1% |
| 2025 2Q | 58억 | -4억 | -5억 | -7.5% |
| 2025 3Q | 57억 | -5억 | -5억 | -9.2% |
| 2025 4Q | 60억 | -3억 | -3억 | -5.4% |
| 2026 1Q | 54억 | -7억 | -8억 | -13.5% |
Company
Address: 충청북도 청주시 흥덕구 오송읍 오송생명6로 63
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.